š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This clinical trial will enroll 160 participants who previously took part i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-15
Trial ID
NCT07744347
It is well recognized that older adults can contract pertussis, suffer its ...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00457249
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519
Objectives: * To present the rates of adverse reactions after a dose of DA...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00802867
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
The primary objective of this pilot study to evaluate the safety of low dos...
Status
Completed
Location
Baylor College of Medicine
Start Date
2017-12-08
Trial ID
NCT03063736
Treatments Being Tested
This study was designed to assess the lot comparability of DAPTACEL, as wel...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00662870
This study is designed to assess the immunogenicity and safety of DTaP vacc...
Status
Completed
Location
Investigational site
Start Date
2014-04
Trial ID
NCT02118961
Pertussis is an acute respiratory infectious disease caused by Bordetella p...
Status
Completed
Location
Shaanxi Center for Disease Control and Prevention
Start Date
2023-12-06
Trial ID
NCT06056050
This clinical trial aims to investigate how exposure to Perfluorononanoic a...
Status
Completed
Location
EOHSI Paulsboro Office
Start Date
2024-11-04
Trial ID
NCT06588530
Treatments Being Tested